Related Experiment Video
Updated: May 17, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Implementing United States Pharmacopeia Chapter . Quality assurance in pharmaceutical compounding, Part 3: Testing
1International Journal of Pharmaceutical Compounding, Inc., Edmond, Oklahoma 73034, USA. lallen@ijpc.com
Abstract:
A good quality-assurance program is guided by written procedures that define responsibilities and practices that ensure compounded preparations are produced with quality attributes that are appropriate to meet the needs of patients and healthcare professionals. It also contains a testing or preparation evaluation component to provide feedback on the accuracy and repeatability of the procedures used in the pharmacy. As a final check, the compounder shall review each procedure in the compounding process to verify it has been followed correctly. To ensure accuracy and completeness, the compounder shall observe the finished preparation to ensure that it appears as expected and shall investigate any discrepancies and take appropriate corrective action before the prescription is dispensed to the patient. In addition, testing may be required or recommended depending upon the situation.
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
In Vitro Drug Dissolution: Compendial Testing Models I
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
In Vitro Drug Dissolution: Compendial Testing Models II
Drug Dissolution: Requirements and Profile Comparison
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

